Clinical Trial Update: Belinostat in Treating Patients With Myelodysplastic Syndromes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update showing completed results for belinostat in myelodysplastic syndromes with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• De Novo Myelodysplastic Syndromes
• Myelodysplastic Syndromes
• Previously Treated Myelodysplastic Syndromes

Drugs mentioned

• BELEODAQ (BELINOSTAT)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes | Phase 2 | Status: COMPLETED | Results posted: 2013-03-20